Abstract:
The present invention relates to a pharmaceutical composition comprising anti-CXCL2 or anti-CXCR2 monoclonal antibody for preventing or treating a graft-versus-host disease. The pharmaceutical composition according to the present invention prevents the graft-versus-host disease and enhances anti-tumor effect by relatively promoting movement of cancer cells by interfering with T-cells from accessing a target organ of the graft-versus-host disease.
Abstract:
본 발명은 시스플라틴으로 인해 유도된 간독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법에 관한 것으로서, 상기 바이오마커 조성물 및 진단방법을 통해, 시스플라틴이 간독성을 일으켰는지의 여부를 용이하게 확인할 수 있다. 시스플라틴은 항암효과가 탁월함에도 불구하고, 간독성이 유발될 수 있어 항암치료에 일부 제한이 있었던 약물이었기에, 상기 방법을 통해 시스플라틴으로 인해 일어나는 간독성을 조기에 진단하여 항암치료 및 간독성 억제를 효과적으로 할 수 있는 방법을 제공한다.
Abstract:
PURPOSE: A composition for digesting fish is provided to remove toxicity and risk by replacing hydrochloric acid with citric acid. CONSTITUTION: A composition for digesting fish contains 3-9% of citric acid and 0.3-3% of pepsin which are mixed in a weight ratio of 3:1-9:1. Citric acid and pepsin are powder. The composition additionally contains water.
Abstract:
PURPOSE: A method for searching a harmful material transition mechanism corresponding to climate change based on data for harmful materials is provided to accurately guarantee food safety. CONSTITUTION: A specific area, a climate factor, and a temporal range of the climate factor are selected for searching a harmful material transition mechanism corresponding to climate change (S100). A harm factor which is utilized for a search of a transition mechanism is selected (S110). The harm factor is generated by harmful materials. Change amount of the climate factor is calculated in the selected area corresponding to the temporal range, and change amount of the harm factor is calculated after searching a database based on the change amount of the climate factor (S120). Change amount of a dangerous factor is calculated through the change amount of the harm factor (S130). [Reference numerals] (S100) Specific area, a climate factor, and a temporal range of the climate factor are selected for searching a harmful material transition mechanism corresponding to climate change; (S110) Harm factor which is utilized for a search of a transition mechanism is selected; (S120) Change amount of the climate factor is calculated in the selected area corresponding to the temporal range, and change amount of the harm factor is calculated after searching a database based on the change amount of the climate factor; (S130) Change amount of a dangerous factor is calculated through the change amount of the harm factor
Abstract:
PURPOSE: A method for determining the mixture of a poultry ingredient in a food using a primer set comprising a forward primer of a certain sequence and a reverse primer of a certain sequence is provided to scientifically monitor foods for prevent distribution of bad foods. CONSTITUTION: A method for determining the mixture of a poultry ingredient in a food comprises: a step of isolating DNA; a step of performing first, second, third, and fourth PCR using a primer set and the DNA as a template; and a step of detecting the poultry ingredient. The primer set is selected from the group consisting of: a primer set comprising a forward primer in sequence number 1 and a reverse primer in sequence number 2 for detecting Gallus gallus; a primer set comprising a forward primer in sequence number 3 and a reverse primer in sequence number 4 for detecting Anas platyrhynchos; a primer set comprising a forward primer in sequence number 5 and a reverse primer in sequence number 6 for detecting Meleagris gallopago; and a primer comprising a forward primer in sequence number 7 and a reverse primer in sequence number 8 for detecting Struthio camelus.
Abstract:
본 발명은 크기 배제 크로마토그래피 방법(size exclusion high performance liquid chromatography, SE-HPLC)을 이용하여 표준항원과 표준항체가 없어도 인플루엔자 백신의 헤마글루티닌의 정량을 가능하게 한 방법으로, 기존에 인플루엔자 백신의 헤마글루티닌을 정량하는 방법인 방사면역확산법(single radial immunodiffusion technique, SRID)보다 헤마글루티닌의 농도를 확인하는 시간이 현저하게 단축되었으면서도 정량 정확도는 더 높아진 헤마글루티닌의 정량 방법이다.
Abstract:
PURPOSE: A harmful drug reaction clue information searching system and a method thereof are provided to use an analyzed drug and a harmful case of the analyzed drug, thereby rapidly and conveniently searching harmful drug reaction clue information. CONSTITUTION: A database unit(101) stores a drug and harmful case information. An analysis object variable selecting unit(103) selects an analysis object variable is about an analyzed drug and harmful case information of the analyzed drug in the database unit. A drug and harmful case information frequency table making unit(104) makes a drug and harmful case information frequency table by using the drug and the harmful case information of the analysis object variable. A clue information index value calculating unit(105) calculates a clue information index value by using the analysis object variable and the drug and harmful case information frequency table. A clue information determining unit(106) determines clue information about the analysis object variable based on the clue information index values. [Reference numerals] (101) Database unit; (102) Basic data inquiring unit; (103) Analysis object variable selecting unit; (104) Drug and harmful case information frequency table making unit; (105) Clue information index value calculating unit; (106) Clue information determining unit; (107) Clue information searching unit; (108) Clue information inquiring unit
Abstract:
본 발명은 세포치료제 제조시 쉽게 오염될 수 있는 세균 및 진균을 검출할 수 있는 핵산증폭 방법, 이 방법에 사용되는 프라이머쌍, 및 이를 포함하는 미생물 검출용 키트에 관한 것이다. 본 발명의 새롭게 제작된 핵산증폭용 프라이머쌍을 이용하면 세포치료제 제조, 보관 및 투여시 쉽게 오염될 수 있는 미생물을 신속하고 정확하며 재현성 있게 검출할 수 있다. 본 발명에서 제안되는 핵산증폭 방법에 의하면 기존의 세포치료제의 무균시험법을 대체하여 경제적이면서 신속하고 정확한 무균시험법을 제공할 수 있는 효과가 있다. 핵산 증폭방법, 중합효소연쇄반응(PCR), PCR 프라이머, 세포치료제, 오염미생물, 병원성미생물, 세균, 진균, 무균시험법, 다중 PCR(multiplex PCR)
Abstract:
PURPOSE: A critical temperature indicator and a manufacturing method thereof which displays critical temperature of freezing and refrigerated food are provided to make mass production and to display a red sign. CONSTITUTION: A critical temperature indicator comprises a lower part(20), a development medium member(21), a time controller, transparent members(40,45) and an upper part. The upper side is dyed in red or the lower part is formed in the base film. The development medium member absorbs the development material. The time controller adheres to the lower part and development medium member. The transparent member is piled up on the development medium member. The transparent member comprises a first display(42) of linear type. The upper part is composed of the opaque body layer equipped with a molding part.
Abstract:
본 발명은 다음의 단계를 포함하는 발암 물질을 검출하는 방법: (a) MOESIN(membrane-organizing extension spike protein) 유전자를 포함하는 세포에 시험물질을 접촉시키는 단계; 및 (b) 상기 세포에서 MOESIN 단백질의 발현 정도를 측정하는 단계; 상기 단백질의 발현이 증가하면 발암 물질로 판정한다; 그리고, 발암 물질 검출용 키트에 관한 것이다. 본 발명에서 발굴된 MOESIN 바이오마커는 발암물질에 대하여 매우 우수한 지표효율성을 나타낸다. 본 발명은 특정 물질의 발암 가능성을 보다 개선된 정확도로 판정하는 데 이용될 수 있다. 또한, 본 발명은 신약 개발 과정 중 안전성 평가에 이용될 수 있다. MOESIN, 발암, 마커, 유전독성